Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

AstraZeneca says lupus treatment gets US FDA approval

27th Apr 2026 08:08

(Alliance News) - AstraZeneca PLC on Monday said its self-administered lupus treatment has been approved in the US. Read More

LONDON BRIEFING: AstraZeneca wins US drug nod; GSK in court ruling

27th Apr 2026 07:58

(Alliance News) - GSK reports on a US court ruling in ongoing litigation, AstraZeneca announces US approval for a self-administered lupus treatment, while Harworth Group receives planning consent for a data centre development in Leeds. Read More

LONDON MARKET CLOSE: Blue chips close lower amid US-Iran stalemate

24th Apr 2026 17:00

(Alliance News) - The FTSE 100 ended the week on the back foot as the crisis in the Middle East remained deadlocked. Read More

IN BRIEF: Arm's Haas to leave AstraZeneca board amid new SoftBank role

23rd Apr 2026 10:39

AstraZeneca PLC - Cambridge, England-based biopharmaceutical maker - Rene Haas will step down as a non-executive director on Thursday next week, the end of April, due to his increased executive duties. Haas is the chief executive officer of UK-based computer-chip designer Arm Holdings PLC and earlier this week was named to the additional role of CEO of SoftBank Group International. Japanese technology investor SoftBank Group Corp remains a major shareholder in Arm following its New York listing in 2023, retaining a 90% stake at the time. Read More

UK earnings, trading statements calendar - next 7 days

22nd Apr 2026 15:13

Read More

AstraZeneca says Ultomiris meets primary endpoint in phase III trial

21st Apr 2026 10:54

(Alliance News) - AstraZeneca PLC on Tuesday reported positive findings from trial results studying its kidney disease treatment, Ultomiris. Read More

AstraZeneca's Tozorakimab meets primary endpoint in "pivotal" trial

20th Apr 2026 09:19

(Alliance News) - AstraZeneca PLC on Monday reported positive phase three results for its monoclonal antibody, Tozorakimab, meeting its primary endpoint in the Miranda trial in patients with chronic obstructive pulmonary disease. Read More

LONDON BROKER RATINGS: Berenberg says 'buy' Elixirr International

10th Apr 2026 09:11

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

UK shareholder meetings calendar - next 7 days

2nd Apr 2026 12:07

Read More

AstraZeneca hails encouraging data for liver cancer drug regimen

2nd Apr 2026 10:46

(Alliance News) - AstraZeneca PLC on Thursday posted encouraging phase-three trial results for its liver cancer treatment combination. Read More

AstraZeneca says hypophosphatasia replacement enzyme trials positive

31st Mar 2026 10:03

(Alliance News) - AstraZeneca PLC on Tuesday said phase-three testing of its replacement efzimfotase alfa enzyme on patients affected by hypophosphatasia yielded positive safety and efficacy results. Read More

LONDON MARKET CLOSE: FTSE 100 ends down as oil rises amid war deadlock

27th Mar 2026 17:07

(Alliance News) - Blue chips in London outperformed European and US peers on Friday, but closed marginally lower, as oil prices rose once more amid few signs of progress in ending the Iran war. Read More

LONDON MARKET MIDDAY: Shares slide as Iran tensions deepen

27th Mar 2026 12:02

(Alliance News) - Stock prices in London were lower at midday Friday, with losses accelerating after a muted open as conflicting signals over Iran weighed on sentiment. Read More

WINNERS & LOSERS: Metlen Energy takes hit from annual results delay

27th Mar 2026 10:30

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More

LONDON MARKET OPEN: Stocks mixed as Brent oil nears USD110

27th Mar 2026 09:04

(Alliance News) - Stock prices in London opened mixed on Friday, with the FTSE 100 edging higher despite continued uncertainty regarding Iran peace talks and muted sentiment across European markets. Read More

AstraZeneca hails positive results in tozorakimab lung disease trials

27th Mar 2026 08:26

(Alliance News) - AstraZeneca PLC on Friday reported positive phase-three trial results for its chronic obstructive pulmonary disease treatment tozorakimab. Read More

LONDON BRIEFING: UK retail sales fall; GSK drug accepted for review

27th Mar 2026 07:56

(Alliance News) - UK retail sales fell in the month of February but by less than expected, while GSK and AstraZeneca hailed positive clinical and regulatory progress. Herald Investment Trust said it will proceed with a backstop tender offer for up to 100% of shares if no agreement is reached with Saba. Read More

Daiichi Sankyo's cancer drug approved as second-line therapy in Japan

23rd Mar 2026 19:13

(Alliance News) - Daiichi Sankyo Co Ltd announced on Monday that Japan's Pharmaceuticals and Medical Devices Agency has approved an update to the prescribing information for its Enhertu treatment, expanding its use to second-line treatment of HER2-positive unresectable advanced or recurrent gastric cancer in Japan. Read More

UK dividends calendar - next 7 days

16th Mar 2026 11:36

Read More

LONDON MARKET OPEN: Shares down as Middle East tensions rise

11th Mar 2026 09:21

(Alliance News) - Stock prices in London opened lower on Wednesday, as renewed tensions in the Middle East stemming from the Israel-US war against Iran kept investors in a cautious mood. Read More

FTSE 100 Latest
Value10,466.26
Change22.79